Risk factors for oral mucositis during chemotherapy treatment for solid tumors: a retrospective STROBE-guided study

BACKGROUND: This study retrospectively analyzed the risk factors for transchemotherapy oral mucositis (OM). MATERIAL AND METHODS: Before each chemotherapy cycle, patients were routinely evaluated for the presence/severity of OM based on the Common Terminology Criteria for Adverse Events (CTCAE) v5.0...

Descripción completa

Detalles Bibliográficos
Autores principales: Martins, Joyce Ohana de Lima, Borges, Marcela Maria Fontes, Malta, Cássia Emanuella Nóbrega, Carlos, Anna Clara Aragão Matos, Crispim, André Alves, de Moura, José Fernando Bastos, Fernandes-Lima, Isabelle Joyce Silva, Silva, Paulo Goberlânio de Barros
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medicina Oral S.L. 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271342/
https://www.ncbi.nlm.nih.gov/pubmed/35717621
http://dx.doi.org/10.4317/medoral.25253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271342/
https://www.ncbi.nlm.nih.gov/pubmed/35717621
http://dx.doi.org/10.4317/medoral.25253

Ejemplares similares